About Us
Mission & Values
SteriTek is committed to providing the highest quality E-beam irradiation services and complete customer support that offers exceptional responsiveness in serving your needs.
Our goal is to create a partnership with you by providing rapid processing and superior business, technical, operational and regulatory support. Our philosophy is very simple: provide the highest standards in the industry – from R&D and testing to validation and production and beyond. All of SteriTek’s E-beam sterilization services meet or exceed, ISO 13485 and 11137 & standards and SAL requirements. We take our QA and QC processes seriously.
So whether you need high-volume, on-demand, or customer services for R&D, testing, validation or production, we make sure your high standards are met every step of the way.
We stand ready to be of service to you and your company!
~ The SteriTek team
Meet our team
Larry Nichols
Chief Executive Officer
Jeff Sauter
Director Business Development
Jordan Fujioka
Director of Operations
Jeff Sauter
Director Business Development
Jeff collaborates with medtech and biotech innovators in helping SteriTek’s customers on their way towards successful commercialization by achieving optimal E-beam/X-ray sterilization and processing throughput of their medical device, combination device, drug/biologic device, or health care product. Jeff has 15 plus years of experience in consulting multinational and Fortune 500 companies and holds a B.A. degree in Economics from the University of Illinois-Chicago.
Jordan Fujioka
Director of Operations
Jordan Fujioka received his Biology degree at the University of California Riverside in 2012. Since then he has moved back to the San Francisco Bay Area where he has worked in the medical device industry for the last 4 years. During his previous employment, he learned the ins and outs of medical device sterilization via E-beam/X-ray irradiation. He now brings this knowledge to SteriTek in order to help guide customers through the validation of terminal sterilization for medical devices.
Larry Nichols
Chief Executive Officer
Larry is involved in all aspects of SteriTek’s business, technical, and sales-side of the company. His cross-functional management background and extensive knowledge and experience in radiation sterilization, and its various applications, has enabled SteriTek to become a leader in the industry. Larry serves as a member on the committee ANSI/AAMI/ISO 11137.
Ray Johal
Operations Manager
Ray oversees all aspects of SteriTek’s high volume E-beam/X-ray sterilization, and R&D processing activities. Ray brings a wealth of operations knowledge and leadership to the organization with over 20 years of experience in the Life Sciences industry.
Eric Nakagawa
Validations Manager
Eric Nakagawa oversees the sterilization validation activities and does audits at SteriTek in accordance with ISO 11137. He brings his experience from biotech, tissue banking, and regulation. He received his Bachelors Degree in Molecular, and Cellular Biology from the University of California Berkeley.
Partners
SteriTek continuously seeks to build partnerships with world class companies providing Testing Services, R&D and Regulatory support. Please visit one of our partners and let’s discuss how we can collaborate!
Our Facilities
SteriTek’s flagship facility in Silicon Valley (Fremont, CA) boasts two state-of-the-art 10 MeV 20 kW linear accelerators, using simultaneous beam processing that allows for high volume production, providing uniform dose to the product without having to rotate the customer’s boxes. This DualBeam™ configuration significantly increases efficiencies, expands product options, and serves as an effective backup for the accelerators.
Our newest facility in Dallas (Lewisville, TX) with operations starting in late 2022 will house three separate lines, two E-beam/X-ray 10 MeV, 30 kW DualBeam™ lines, and a dedicated X-ray 7 MeV, 560 kW line which together will increase the total throughput by fivefold, once in full operation.
SteriTek Raleigh-Durham/Greensboro area will be in operation in mid-2024 housing three separate lines with 2400 total kW power, once in full operation.